Mylan Sold Its Soul – Will Your Sales Team?
OpenSymmetry
NOVEMBER 3, 2016
Just last year, in 2015, CEO Martin Shkreli of Turing Pharmaceuticals was under fire for buying the drug Daraprim from Impax Laboratories and raising the price from $13.50 Mylan’s Executive Compensation Structure – The Incentive Plan that Started It All. What is the correlation here?
Let's personalize your content